Skip to main content
    O

    Oruka Therapeutics, Inc. (ORKA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $99.24
    -6.11 (-5.80%)

    Market Cap: $7.15B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Oruka Therapeutics, Inc. (ORKA) Earnings: Report Dates and Results

    Updated Nov 9, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Oruka Therapeutics (ORKA) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, Oruka Therapeutics reported EPS of -$0.63, above the -$0.68 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    73%(16/22)
    Avg Surprise
    -24.06%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 10, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.69
    Range-$0.98 - -$0.38
    14 analysts
    Revenue Consensus
    N/A
    RangeN/A
    12 analysts
    Reports May 11, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.73
    Range-$0.88 - -$0.60
    5 analysts
    EPS Revisions
    1
    4
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.68-7.1%
    60d ago-$0.72-0.6%
    30d ago-$0.72-0.6%
    7d ago-$0.72-0.6%
    Current-$0.73
    Revenue Consensus
    N/A
    RangeN/A
    6 analysts

    Next Report

    ORKA has an expected report date of Mar 10, 2027.

    Earnings History

    Of the 22 quarters below that had an estimate, ORKA beat 16 and missed 6. The widest gap in the table came in the quarter ended Sep 30, 2018, when EPS landed 942.11% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.63-$0.68-$0.79 - -$0.41+7.35%BeatN/A91 up, 7 downNov 9, 2026
    Jun 30, 2026-$0.55-$0.49-$0.67 - -$0.41-12.24%MissN/A97 up, 2 downAug 10, 2026
    Mar 31, 2026-$0.48-$0.54-$0.65 - -$0.47+11.11%BeatN/A80 up, 2 downMay 13, 2026
    Dec 31, 2025-$0.45-$0.62-$0.85 - -$0.47+26.90%BeatN/A81 up, 1 downMar 12, 2026
    Sep 30, 2025-$0.55-$0.52-$0.60 - -$0.40-5.77%MissN/A51 up, 0 downNov 12, 2025
    Jun 30, 2025-$0.46-$0.43-$0.52 - -$0.31-6.98%MissN/A41 up, 2 downAug 11, 2025
    Mar 31, 2025-$0.40-$0.44N/A+9.09%BeatN/AN/AN/AMay 14, 2025
    Dec 31, 2024-$0.54-$0.41-$0.46 - -$0.20-31.71%MissN/A31 up, 0 downMar 6, 2025
    Sep 30, 2024-$1.46-$0.32-$0.45 - -$0.20-356.25%MissN/A41 up, 0 downNov 13, 2024
    Jun 30, 2024-$2.22N/AN/AN/AN/AN/AN/AN/AAug 27, 2024
    Mar 31, 2024-$0.14N/AN/AN/AN/AN/AN/AN/AApr 25, 2024
    Dec 31, 2023-$0.90N/AN/AN/AN/AN/AN/AN/AFeb 1, 2024
    Sep 30, 2023-$1.19N/AN/AN/AN/AN/AN/AN/ANov 7, 2023
    Jun 30, 2023-$1.23N/AN/AN/AN/AN/AN/AN/AJul 21, 2023
    Mar 31, 2023-$0.09N/AN/AN/AN/AN/AN/AN/AJun 29, 2023
    Dec 31, 2022-$0.08N/AN/AN/AN/AN/AN/AN/AMar 30, 2023
    Sep 30, 2022-$0.16N/AN/AN/AN/AN/AN/AN/AOct 28, 2022
    Jun 30, 2022-$0.22N/AN/AN/AN/AN/AN/AN/AAug 2, 2022
    Mar 31, 2022-$0.55N/AN/AN/AN/AN/AN/AN/AJun 29, 2022
    Dec 31, 2021-$0.55-$2.24N/A+75.45%BeatN/AN/AN/AMar 30, 2022
    Sep 30, 2021-$0.33-$2.30N/A+85.65%BeatN/AN/AN/ANov 2, 2021
    Jun 30, 2021-$0.34-$2.37N/A+85.65%BeatN/AN/AN/AAug 4, 2021
    Mar 31, 2021-$0.33-$1.87N/A+82.35%BeatN/AN/AN/AJun 29, 2021
    Dec 31, 2020-$0.55-$2.44N/A+77.46%BeatN/AN/AN/AMar 30, 2021
    Sep 30, 2020-$0.33-$2.51N/A+86.85%BeatN/AN/AN/ANov 2, 2020
    Jun 30, 2020-$0.73-$2.58N/A+71.71%BeatN/AN/AN/AAug 5, 2020
    Mar 31, 2020-$0.83-$2.04N/A+59.31%BeatN/AN/AN/AJun 29, 2020
    Dec 31, 2019-$0.39-$0.99N/A+60.61%BeatN/AN/AN/AMar 30, 2020
    Sep 30, 2019-$0.76-$1.30N/A+41.54%BeatN/AN/AN/ANov 6, 2019
    Jun 30, 2019-$1.14-$1.86N/A+38.71%BeatN/AN/AN/AAug 1, 2019
    Mar 31, 2019-$1.86-$1.98N/A+6.06%BeatN/AN/AN/AJun 29, 2019
    Dec 31, 2018-$1.98-$0.14N/AN/AN/AN/AN/AN/AMar 30, 2019
    Sep 30, 2018-$1.98-$0.19N/A-942.11%MissN/AN/AN/ANov 14, 2018
    Jun 30, 2018-$2.70-$0.22N/AN/AN/AN/AN/AN/AAug 9, 2018
    Mar 31, 2018-$43.37N/AN/AN/AN/AN/AN/AN/AJun 29, 2018
    Dec 31, 2017-$76.99N/AN/AN/AN/AN/AN/AN/AMar 30, 2018
    Sep 30, 2017-$83.24N/AN/AN/AN/AN/AN/AN/ANov 10, 2017
    Jun 30, 2017-$127.91N/AN/AN/AN/AN/AN/AN/AAug 15, 2017
    Mar 31, 2017-$103.03N/AN/AN/AN/AN/AN/AN/AJun 29, 2017
    Dec 31, 2016-$100.93N/AN/AN/AN/AN/AN/AN/AMar 30, 2017
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.86, after -$4.36 the year before. It was -$391.70 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.86N/A
    Dec 31, 2024-$4.36N/A
    Dec 31, 2023-$3.41N/A
    Dec 31, 2022-$1.01N/A
    Dec 31, 2021-$1.55N/A
    Dec 31, 2020-$2.44N/A
    Dec 31, 2019-$4.15N/A
    Dec 31, 2018-$50.03N/A
    Dec 31, 2017-$391.18N/A
    Dec 31, 2016-$391.70N/A

    Frequently Asked Questions About ORKA

    When is Oruka Therapeutics's next earnings date?

    Oruka Therapeutics's next earnings report is expected for Mar 10, 2027.

    Did ORKA beat earnings estimates last quarter?

    Yes. Oruka Therapeutics reported EPS of -$0.63 for the quarter ended Sep 30, 2026, above the -$0.68 estimate, a 7.35% surprise.

    What EPS do analysts expect from ORKA next quarter?

    The consensus EPS estimate for Oruka Therapeutics for the quarter ending Dec 31, 2026 is -$0.69 from 14 analysts, with estimates from -$0.98 to -$0.38.

    How often does ORKA beat earnings estimates?

    Oruka Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -0.28%.